Genetic architecture of human fibrotic diseases: Disease risk and disease progression

5Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Genetic studies of human diseases have identified multiple genetic risk loci for various fibrotic diseases. This has provided insights into the myriad of biological pathways potentially involved in disease pathogenesis. These discoveries suggest that alterations in immune responses, barrier function, metabolism and telomerase activity may be implicated in the genetic risks for fibrotic diseases. In addition to genetic disease-risks, the identification of genetic disease-modifiers associated with disease complications, severity or prognosis provides crucial insights into the biological processes implicated in disease progression. Understanding the biological processes driving disease progression may be critical to delineate more effective strategies for therapeutic interventions. This review provides an overview of current knowledge and gaps regarding genetic disease-risks and genetic disease-modifiers in human fibrotic diseases.

Cite

CITATION STYLE

APA

Gardet, A., Zheng, T. S., & Viney, J. L. (2013). Genetic architecture of human fibrotic diseases: Disease risk and disease progression. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2013.00159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free